about
Colistin for lung infection: an updateHigh dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi ArabiaClinical and economic outcomes of Acinetobacter vis a vis non-Acinetobacter infections in an Indian teaching hospital.The risk factors of colistin methanesulfonate associated nephrotoxicity.Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapyColistin: efficacy and safety in different populations.Strategies for the safe use of colistin.The safety of polymyxin antibiotics.Good tolerability of high dose colistin-based therapy in patients with haematological malignancies.Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.Luteolin ameliorates colistin-induced nephrotoxicity in the rat models.Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study.Survival or Safety: Balancing act with Colistin.Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment
P2860
Q28082041-B65E5348-BB9D-4725-8E0D-730D91CB03ABQ34994417-326A98FC-E30E-4BC3-9EA9-97ADC746182EQ36606740-0D665455-B961-4AE5-9F96-7101D3D27142Q37041117-6E85DA1E-6A5E-409D-BD9D-F33764A507F9Q37480886-4045EEE8-5C51-42E6-9123-D3E0BB37BBD8Q38514980-4B2A8D08-AAE0-4761-9712-B63672462A6EQ38548658-BD92700E-4FE2-4C67-9022-34A05A57842CQ38586123-27BA278F-8184-49EC-9925-D6C5617D4B98Q38869608-F90D3003-419E-4DEC-907B-A0ABD177A261Q40234980-AAE5CDAF-92C9-4175-9047-14585103DCE0Q40495606-3DF192AE-9AFA-4219-853B-CA6B9989106CQ41007716-BBD13E72-347A-47D8-9247-4B08373A4257Q41532045-2C2CD4FA-1C5D-4F9D-BFA6-F74A957898C3Q43159930-6880EA95-650D-4863-8F70-8D53C7CBAD7FQ52382327-7C5A430F-E45D-48A2-BD30-A4C55EBE13B8Q52640045-34C0188C-E220-4BE7-9D81-333E59A632C1Q58790968-C5C21CB2-4265-4ACF-AFE6-C2F5BE2DF97E
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Colistin nephrotoxicity increases with age.
@en
Colistin nephrotoxicity increases with age.
@nl
type
label
Colistin nephrotoxicity increases with age.
@en
Colistin nephrotoxicity increases with age.
@nl
prefLabel
Colistin nephrotoxicity increases with age.
@en
Colistin nephrotoxicity increases with age.
@nl
P2093
P2860
P1476
Colistin nephrotoxicity increases with age.
@en
P2093
Ahmet Selim Ozkan
Asiye Bahar Kacmaz
Ayse Batirel
Birsen Cetin
Bulent Durdu
Fehmi Tabak
Ibak Gonen
Ilker Inanc Balkan
Muhammed Emin Demirkol
P2860
P304
P356
10.3109/00365548.2014.926021
P577
2014-07-30T00:00:00Z